We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Grape Seed Extracts Blocks Formation of Toxic Amyloid-Beta Oligomers in Brain Tissue

By LabMedica International staff writers
Posted on 27 Jul 2011
Compounds present in grape seed polyphenolic extract (GSPE) may protect against the development of Alzheimer’s disease by blocking the formation of toxic amyloid-beta (A-beta) oligomers in brain tissue.

Previous studies have found that increased consumption of grape-derived polyphenols, such as those found in red wine, may protect against cognitive decline in Alzheimer’s disease. More...
In the current study, investigators at Mount Sinai School of Medicine (New York, NY, USA) and their colleagues at the University of Minnesota (Minneapolis, USA) treated Tg2576 mice – a well-known rodent Alzheimer’s disease model – with GSPE for a period of five months.

They reported in the July 2011 online edition of the Journal of Alzheimer’s Disease that the treatment significantly decreased brain levels of A-beta*56, a 56-kDa A-beta oligomer previously shown to induce memory dysfunction in rodents, without changing the levels of transgenic amyloid-beta protein precursor, monomeric A-beta, or other A-beta oligomers.

“It will be critical to identify subjects who are at high risk of developing Alzheimer’s disease, so that we can initiate treatments very early and possibly even in asymptomatic patients,” said senior author Dr. Giulio Maria Pasinetti, professor of psychiatry and geriatrics at the Mount Sinai School of Medicine. “However, for Alzheimer’s disease patients who have already progressed into the initial stages of the disease, early intervention with this treatment might be beneficial as well. Our study implicating that these neurotoxins such as A-beta*56 in the brain are targeted by grape-derived polyphenols holds significant promise.”

“Since naturally occurring polyphenols are also generally commercially available as nutritional supplements and have negligible adverse events even after prolonged periods of treatment, this new finding holds significant promise as a preventive method or treatment, and is being tested in translational studies in Alzheimer’s disease patients,” said Dr. Pasinetti.

Since the results of this study showed that a safe and affordable intervention could lower the levels of a memory-impairing A-beta oligomer in vivo, the authors strongly suggested that GSPE should be further tested as a potential prevention and/or therapy for Alzheimer’s disease.

Related Links:
Mount Sinai School of Medicine
University of Minnesota


New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.